These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effects of metoprolol on blood pressure and plasma renin activity in thiazide-resistant hypertensive patients. Velasquez MT; Han Wan S; Maronde RF Clin Pharmacol Ther; 1979 Nov; 26(5):555-61. PubMed ID: 498696 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension. von Bahr C; Collste P; Frisk-Holmberg M; Haglund K; Jorfelt L; Orme M; Ostman J; Sjoqvist F Clin Pharmacol Ther; 1976 Aug; 20(2):130-7. PubMed ID: 7373 [TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with tibalosine in essential hypertension. Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092 [TBL] [Abstract][Full Text] [Related]
10. The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension. Pitkäjärvi T; Ylitalo P; Metsä-Ketelä T; Vapaatalo H Acta Med Scand; 1979; 206(1-2):107-13. PubMed ID: 484251 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tolamolol in the treatment of hypertension. Routledge PA; Davies DM; Rawlins MD Eur J Clin Pharmacol; 1977 Nov; 12(3):171-4. PubMed ID: 579342 [TBL] [Abstract][Full Text] [Related]
12. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension. Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359 [TBL] [Abstract][Full Text] [Related]
13. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension. Epstein SE; LUbbe WF S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effect of trimepranol, a new beta-blocking agent. Jounela AJ; Pentikäinen PJ; Neuvonen PJ Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):183-8. PubMed ID: 25847 [TBL] [Abstract][Full Text] [Related]
15. [The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)]. Hata S Nihon Naibunpi Gakkai Zasshi; 1977 Oct; 53(10):1129-39. PubMed ID: 22466 [TBL] [Abstract][Full Text] [Related]
16. Effects of tertatolol in hypertensive patients with chronic renal failure. Beaufils M; Lantz B; Paillard F; Richet G Am J Nephrol; 1986; 6 Suppl 2():50-4. PubMed ID: 2879474 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias. Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients. Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473 [TBL] [Abstract][Full Text] [Related]
19. Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity. Nilsson OR; Karlberg BE; Ohlsson O; Thulin T; Tolagen K Acta Med Scand; 1979; 206(4):303-8. PubMed ID: 506802 [TBL] [Abstract][Full Text] [Related]
20. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study. Jackson B; Morgan TO; Gibson J; Anderson A Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]